AstraZeneca Pharma India Limited reports a change in its board or management
In short
AstraZeneca Pharma India Limited informed the exchange about a change in its directors, KMP, SMP, auditor or RTA on the date of the filing. In simple terms, the company notified the stock exchange that something in its leadership, key management, auditor, or registrar-and-transfer setup has changed. No closing date, deadline, or validity period is stated.
Why it matters
A change at the leadership or audit level — worth checking who's departing/joining and whether the filing gives a reason. This brief was written from the filing itself: at the time of writing, no publisher in our feed had covered it.